MANE: the cash flow

MyFinsight

For the year ending 2025-12-31, MANE had -$31,318K decrease in cash & cash equivalents over the period. -$71,626K in free cash flow.

Cash Flow	2025-12-31
Net loss	-69,995
Stock-based compensation	1,440
Research and development expenses paid with convertible and promissory notes	0
Non-cash research and development services	1,999
Net accretion of discount/premium on debt securities	556
Accrued interest earned	647
Other	-43
Prepaid expenses and other current assets	8,235
Accounts payable	-122
Accrued expenses	4,510
Other current liabilities and lease liabilities	-39
Net cash used in operating activities	-71,602
Purchase of property, plant and equipment	24
Purchases of marketable securities	143,852
Maturities of marketable securities	25,018
Net cash used in investing activities	-118,858
Issuance of convertible notes	0
Issuance of preferred stock-Series BPreferred Stock	8,433
Issuance of preferred stock-Series CPreferred Stock	151,000
Payment of promissory note	0
Preferred stock issuance costs	447
Exercise of stock options	156
Net cash provided by financing activities	159,142
Net increase (decrease) in cash and cash equivalents	-31,318
Cash and cash equivalentsbeginning of year	53,084
Cash and cash equivalentsend of year	21,766

Unit: Thousand (K) dollars (except for numbers of shares and EPS).